Amgen’s Blincyto has been granted a full European licence in a form of blood cancer following data showing the drug almost doubled overall survival time compared with standard therapy.

Associate Professor Shaun Fleming said the listing of Blincyto meant patients could avoid the potentially fatal side effects of chemotherapy. “Typically, patients with ALL are being treated with ...

An air source heat pump is an alternative way to heat your home. It will help you reduce your impact on the environment and potentially save you money on your energy bills in the long run. Heat pumps ...